Patents Examined by Prema Maria Mertz
  • Patent number: 10076555
    Abstract: Described herein are methods and compositions for inducing melanogenesis in a human subject. The method comprises administering to a subject an alpha-MSH analogue, in an effective amount and time to induce melanogenesis by the melanocytes in epidermal tissue of subject without inducing homologous desensitization of the melanocortin-1 receptors.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: September 18, 2018
    Assignee: Clinuvel Pharmaceuticals Limited
    Inventors: Michael John Kleinig, Thomas R. Tice, Jay K. Staas